Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA
Breast Cancer · 2024
DOI: 10.1007/s12282-024-01627-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer, 2024. Verfasst von Yu-Tien Chang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, National Defense Medical Center, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Breast cancer (BC) is the most common cancer in women and accounts for approximately 15% of all cancer deaths among women globally. The underlying mechanism of BC patients with small tumor size and developing distant metastasis (DM) remains elusive in clinical practices.
Methods
We integrated the gene expression of BCs from ten RNAseq datasets from Gene Expression Omnibus (GEO) database to create a genetic prediction model for distant metastasis-free survival (DMFS) in BC patients with small tumor sizes (≤ 2 cm) using weighted gene co-expression network (WGCNA) analysis and LASSO cox regression.
Results
ABHD11, DDX39A, G3BP2, GOLM1, IL1R1, MMP11, PIK3R1, SNRPB2, and VAV3 were hub metastatic genes identified by WGCNA and used to create a risk score using multivariable Cox regression. At the cut-point value of the median risk score, the high-risk score (≥ median risk score) group had a higher risk of DM than the low-risk score group in the training cohort [hazard ratio (HR) 4.51, p < 0.0001] and in the validation cohort (HR 5.48, p = 0.003). The nomogram prediction model of 3-, 5-, and 7-year DMFS shows good prediction results with C -indices of 0.72–0.76. The enriched pathways were immune regulation and cell–cell signaling. EGFR serves as the hub gene for the protein–protein interaction network of PIK3R1, IL1R1, MMP11, GOLM1, and VAV3.
Conclusion
Prognostic gene signature was predictive of DMFS for BCs with small tumor sizes. The protein–protein interaction network of PIK3R1, IL1R1, MMP11, GOLM1, and VAV3 connected by EGFR merits further experiments for elucidating the underlying mechanisms. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, National Defense Medical Center, Taipei City, Taiwan.
- Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Chenggong Rd., Neihu Dist., Taipei City, 114202, Taiwan.
- Department of Surgery, Taipei Veterans General Hospital, No.201, Sec. 2, Shipai Rd., Beitou District, Taipei City, 11217, Taiwan.
- Comprehensive Breast Health Center, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei City, 11217, Taiwan.
- Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, No. 17, Xuzhou Rd., Taipei City, 100, Taiwan.
- AIoT Center, Tri-Service General Hospital, Taipei City, Taiwan.
Förderung
- Tri-Service General Hospital
Zitieren
APA
Chang, Y. T., Hong, Z. J., Tsai, H. H., Feng, A. C., Huang, T. Y., Yu, J. C., Hsu, K. F., Huang, C. C., Lin, W. Z., Chu, C. M., Liang, C. M., & Liao, G. S. (2024). Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA. Breast Cancer. https://doi.org/10.1007/s12282-024-01627-w
Vancouver
Chang YT, Hong ZJ, Tsai HH, Feng AC, Huang TY, Yu JC, et al. Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA. Breast Cancer. 2024. doi:10.1007/s12282-024-01627-w
BibTeX
@article{Chang2024,
author = {Chang, Yu-Tien and Hong, Zhi-Jie and Tsai, Hsueh-Han and Feng, An-Chieh and Huang, Tzu-Ya and Yu, Jyh-Cherng and Hsu, Kuo-Feng and Huang, Chi-Cheng and Lin, Wei-Zhi and Chu, Chi-Ming and Liang, Chia-Ming and Liao, Guo-Shiou},
title = {Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA},
journal = {Breast Cancer},
year = {2024},
doi = {10.1007/s12282-024-01627-w}
}
EUVIMED